NCT03893331 (DISCOVER) is a clinical trial of AcQMap System in Ablation of Arrhythmia's, sponsored by Acutus Medical.

Who is sponsoring NCT03893331?

NCT03893331 is sponsored by Acutus Medical.

What drugs are being tested in NCT03893331?

Interventions in NCT03893331: AcQMap System.

What condition does NCT03893331 study?

NCT03893331 studies Ablation of Arrhythmia's.

Is NCT03893331 still recruiting?

NCT03893331 is currently terminated. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT03893331: DISCOVER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)

Terminated Last updated 13 November 2023

What this trial tests

trial testing AcQMap System in Ablation of Arrhythmia's in 479 participants. Terminated before completion.

Timeline

13 June 2019

Primary endpoint
8 November 2023

8 November 2023

Quick facts

Lead sponsor	Acutus Medical
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	479
Start date	13 June 2019
Primary completion	8 November 2023
Estimated completion	8 November 2023
Sites	12 locations across France, Netherlands, Germany, United Kingdom

Drugs / interventions tested

AcQMap System

Conditions studied

Ablation of Arrhythmia's — all drugs for Ablation of Arrhythmia's →

Sponsor

Acutus Medical

Who can join

18 and older, any sex, with Ablation of Arrhythmia's. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

AcQMap Registry is an observational study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Global Substrate Mapping and Targeted Ablation with Novel Gold-tip Catheter in <i>De Novo</i> Persistent AF.
Pope MT, Betts TR. · · 2022 · cited 1× · PMID 35755327 · DOI 10.15420/aer.2021.64

Verify or expand the search:

Other trials of AcQMap System

Trials testing the same drug.

NCT04431544 — AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US) · terminated
NCT02825992 — Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation · NA · completed

Other Acutus Medical trials

Trials by the same sponsor.

NCT04904354 — AcQBlate Force Sensing Ablation System US IDE Study for Atrial Fibrillation · NA · withdrawn
NCT04512794 — Pulmonary Vein Isolation Plus Left Atrial Slow Zone Mapping and Ablation · NA · withdrawn
NCT05181878 — AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study) · completed
NCT05113056 — AcQForce Pulsed Field Ablation-CE · NA · completed
NCT04658940 — AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03893331 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Acutus Medical
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03893331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing